Advanced B-cell Lymphoid Malignancies Recruiting Phase 0 Trials for Roflumilast (DB01656)

IndicationStatusPhase
DBCOND0063933 (Advanced B-cell Lymphoid Malignancies)Recruiting0
clinicaltrials.gov IdentifierTitlePurposeDrugs